Delivery Order SPE2DB24D2205-SPE2DB26FDSMC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a contract ceiling value of $2,603.50. This delivery order represents a firm fixed-price procurement with an ultimate completion date of August 21, 2025, and was competitively awarded without set-aside provisions. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units, with a ceiling value of $12,332.70 and firm fixed pricing. This non-set-aside competitive delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Azithromycin 500 mg tablets (30-count packaging) with a ceiling value of $9,828.00. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set to be completed by July 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14,742.00 delivery order to AmerisourceBergen Drug Corp for Azithromycin 500 mg tablets (30-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price contract was awarded without a set-aside designation through competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply chains, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $73,152.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets (30-count units) under a firm fixed-price contract valued at $9,536.32. The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements, with performance to take place at the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 per unit, with a ceiling value of $8,271.78. This competitive award, issued without set-aside designation, is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,683.84 to AmerisourceBergen Drug Corp for the supply of Azithromycin 250 mg tablets in packages of six units. This competitive, firm fixed-price delivery order was issued on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB26FDSMCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $9,542.76 with firm fixed pricing and is scheduled for completion by October 20, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply agreement running through December 2026. As a prime vendor within the DLA Medical Supply Chain, AmerisourceBergen supplies critical pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal procurement portfolio demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic categories, from generic medications to specialty pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 10/17/25 |